Follitropin alfa biosimilar (GEMA)

促卵泡激素α生物类似药 (GEMA)

Report date: 2022/07/04 19:38:02

Base Information

Drug NameFollitropin alfa biosimilar (GEMA)

Drug Alias Name促卵泡激素α生物仿制药 (GEMA)r-hFSH biosimilar-GEMAFolitime

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants

TargetsFollicle-stimulating hormone receptor

Therapy Area/IndicationsInfertility

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryArgentina

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGema Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGema Biotech Sa

Active IndicationsN/A

Inactive IndicationsInfertility

ATC CodeG03GA05